Private Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Private Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-79,727	Closed	-$8.91M	–	96
2019 Q1	$8.91M	Sell	79,727 -754	-0.9%	-$82.7K	2.7%	10
2018 Q4	$7.76M	Hold	80,481	–	–	2.78%	9
2018 Q3	$9.81M	Buy	80,481 +724	+0.9%	+$85.3K	2.71%	7
2018 Q2	$8.76M	Sell	79,757 -12,860	-14%	-$1.38M	2.74%	6
2018 Q1	$9.89M	Buy	92,617 +73,184	+377%	+$8.11M	3.29%	5
2017 Q4	$2.08M	Buy	19,433 +14,000	+258%	+$1.5M	0.72%	39
2017 Q3	$604K	Sell	5,433 -9,567	-64%	-$1.02M	0.21%	73
2017 Q2	$1.55M	Buy	+15,000	New	+$1.48M	0.5%	50
2016 Q3	–	Sell	-5,640	Closed	-$484K	–	113
2016 Q2	$484K	Buy	+5,640	New	+$506K	0.18%	81

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Private Capital Advisors's IBB Position: Q2 2019 in Review

Private Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 79,727 shares — an estimated $8.91M sold.

Private Capital Advisors first reported a position in IBB in Q2 2016 and held it in 9 quarters. The position peaked at $9.89M in Q1 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Private Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Private Capital Advisors sold 79,727 iShares Biotechnology ETF shares in Q2 2019, an estimated $8.91M.
Private Capital Advisors first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 9 quarters.
Private Capital Advisors's iShares Biotechnology ETF position peaked at $9.89M in Q1 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Private Capital Advisors's 13F filing for Q2 2019, filed 18 Jul 2019.